Cell membrane lipids and lipid metabolism pathways implicated in CFTR stabilization and inflammation resolution

Cell membrane lipids and their metabolic pathways are critical determinants of the structural stability and functional regulation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein. In Cystic Fibrosis (CF), the lipid composition of the plasma membrane is significantly altered, often characterized by an accumulation of pro-inflammatory ceramide and a deficiency in specialized pro-resolving mediators (SPMs) such as Lipoxin A4 (Grassmé et al., 2008, Nature Medicine; Karp et al., 2004, Nature Immunology). These lipid imbalances not only destabilize CFTR at the cell surface but also drive the chronic, non-resolving inflammation and heightened susceptibility to bacterial infections that define CF lung disease. Therapeutic strategies targeting these pathways aim to restore lipid homeostasis by inhibiting enzymes like acid sphingomyelinase (ASM) to reduce ceramide or by administering SPM analogs to activate resolution receptors (Abu-Arish et al., 2015, Journal of Biological Chemistry). Such approaches represent a novel paradigm in CF treatment, focusing on the cellular environment to complement direct CFTR modulation and address the persistent inflammatory burden.

Other names

CFTR-lipid signaling axisSphingolipid metabolism in Cystic FibrosisSpecialized pro-resolving mediator pathwaysBioactive lipid signaling in CF

Modulation of the lipid environment to enhance CFTR plasma membrane stability and activation of pro-resolution signaling pathways to terminate chronic inflammation (Grassmé et al., 2008; Karp et al., 2004).